{"id":21830,"date":"2021-06-08T15:13:06","date_gmt":"2021-06-08T13:13:06","guid":{"rendered":"https:\/\/ela-international.preprod.melisagency.fr\/?post_type=news&p=21830"},"modified":"2024-08-16T09:40:42","modified_gmt":"2024-08-16T07:40:42","slug":"2021-major-advance-treatment-adrenoleukodystrophy","status":"publish","type":"news","link":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/","title":{"rendered":"2021 : A major advance in the treatment of adrenoleukodystrophy"},"content":{"rendered":"\n\n
\n
\n

Thanks to ELA’s massive investment in research into cerebral ALD, in 2009 the team led by Prof. Patrick Aubourg and Dr. Nathalie Cartier published the first results of a gene therapy trial for cerebral adrenoleukodystrophy conducted in France. This work was then continued internationally by the Bluebird Bio laboratory, which conducted the phase 2\/3 trial.<\/strong>
\nOn 21 May 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) gave a favourable opinion for marketing authorisation for gene therapy for the treatment of cerebral adrenoleukodystrophy, and on 21 July 2021, the European Commission (EC) granted marketing authorisation.<\/strong>
\nThis is a historic breakthrough in the treatment of adrenoleukodystrophy.<\/strong><\/p>\n\n \n\n \n Read BluebirdBio press release (French) <\/a>\n \n \n <\/path>\n <\/svg>\n\n Read BluebirdBio press release (French)<\/span>\n \n <\/a>\n\n\n <\/div>\n<\/div>\n\n\n\n\n

<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":21834,"parent":0,"template":"","news_categories":[13,97],"class_list":["post-21830","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-international","news_categories-international-en"],"acf":[],"yoast_head":"\n2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/\" \/>\n<meta property=\"og:site_name\" content=\"ELA International\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-16T07:40:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/08\/aubourg2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"430\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/\",\"name\":\"2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/aubourg2.jpg\",\"datePublished\":\"2021-06-08T13:13:06+00:00\",\"dateModified\":\"2024-08-16T07:40:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/aubourg2.jpg\",\"contentUrl\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/aubourg2.jpg\",\"width\":770,\"height\":430},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/2021-major-advance-treatment-adrenoleukodystrophy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2021 : A major advance in the treatment of adrenoleukodystrophy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/\",\"name\":\"ELA International\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/","og_locale":"en_US","og_type":"article","og_title":"2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International","og_url":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/","og_site_name":"ELA International","article_modified_time":"2024-08-16T07:40:42+00:00","og_image":[{"width":770,"height":430,"url":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/08\/aubourg2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/","url":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/","name":"2021 : A major advance in the treatment of adrenoleukodystrophy - ELA International","isPartOf":{"@id":"https:\/\/elainternational.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/#primaryimage"},"image":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/#primaryimage"},"thumbnailUrl":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/08\/aubourg2.jpg","datePublished":"2021-06-08T13:13:06+00:00","dateModified":"2024-08-16T07:40:42+00:00","breadcrumb":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/#primaryimage","url":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/08\/aubourg2.jpg","contentUrl":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/08\/aubourg2.jpg","width":770,"height":430},{"@type":"BreadcrumbList","@id":"https:\/\/elainternational.eu\/en\/actualites\/2021-major-advance-treatment-adrenoleukodystrophy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elainternational.eu\/en\/"},{"@type":"ListItem","position":2,"name":"2021 : A major advance in the treatment of adrenoleukodystrophy"}]},{"@type":"WebSite","@id":"https:\/\/elainternational.eu\/en\/#website","url":"https:\/\/elainternational.eu\/en\/","name":"ELA International","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elainternational.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news\/21830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/users\/6"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/media\/21834"}],"wp:attachment":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/media?parent=21830"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news_categories?post=21830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}